The latest round of financial results is one bright spot that might carry stocks to new highs, despite this year's turmoil. ...

CENTENNIAL, CO / ACCESS Newswire / February 27, 2026 / Nepra Foods Inc. (CSE:NPRA)(OTCQB:NPRFF) ("Nepra" or the "Company"), a vertically integrated gluten-free and better-for-you specialty ingredient and consumer products company, today announced its financial results for the three and nine months ended December 31, 2025. All figures are in Canadian dollars unless otherwise noted. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Insights - Genomma Lab Internacional reported a challenging year in 2025, with like-for-like sales declining by -4.3% due to a weak summer beverage season and a softer consumption environment in Mexico [1] - The company achieved a year-end EBITDA margin of 23.4%, demonstrating strong business fundamentals despite topline pressure [1] - Genomma Lab anticipates that growth initiatives will gain traction in the second half of 2026, supporting a recovery in operational leverage [1] Financial Performance Summary - Q4 2025 net sales decreased by -13.9% to MXN 4,017 million, while full-year net sales fell by -5.7% to MXN 17,541 million [1] - Gross profit for Q4 2025 was MXN 2,449 million, a decline of -16.7% year-over-year, with a full-year gross profit of MXN 11,022 million, down -7.6% [1] - Net income from continuous operations decreased by -23.1% for the full year 2025, totaling MXN 1,607 million, and declined by -13.0% in Q4 2025 to MXN 319 million [1] Operational Highlights - The company unlocked MXN 1.1 billion in productivity savings to reinvest in growth initiatives, including product innovation and distribution expansion [1] - The cash-conversion cycle remained healthy at 107 days, indicating effective management of working capital [1] - Despite a -2.2% decline in Mexico sell-out during Q4, underlying consumer demand was confirmed to be resilient [1]

SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial results for the quarter and year ended December 31, 2025. Full year 2025 revenues rose to a record $3.18 billion, reflecting 11% growth over 2024. "As we close out another remarkable year with record total revenue for the fourth year in a row, I extend my thanks to our Unitherians whose unwavering commitment to innovation. ...

Core Insights - Taseko Mines reported strong operational performance in Q4, with Gibraltar producing 31 million pounds of copper and achieving a copper head grade of 0.26% and recoveries of 81% [1] - The company highlighted the commencement of copper production at the Florence Copper project, with expectations for increased output in 2026 [7][12] Operational Performance - Gibraltar's throughput was approximately 8% below design capacity due to unscheduled mill downtime, which slightly offset the benefits of higher grades and recoveries [1] - Molybdenum production reached 800,000 pounds in Q4, marking the best production quarter in the mine's history [8] - Total operating costs declined to $2.47 per pound in Q4, with full-year 2025 costs at $2.66 per pound [9] Production Outlook - For 2026, Gibraltar is expected to produce 110–115 million pounds of copper, with management targeting throughput around design capacity of 85,000 tonnes per day [12][13] - The company plans to add 80–100 new wells annually at the Florence project, with initial results from wellfield operations described as "very positive" [3][5] Financial Performance - Taseko reported total quarterly revenue of CAD 244 million in Q4, including CAD 25 million from molybdenum revenue [14] - For full-year 2025, the company recorded CAD 673 million in revenue from sales of 99 million pounds of copper and 1.9 million pounds of molybdenum [15] - Adjusted EBITDA for Q4 was CAD 116 million, significantly higher than the prior-year quarter [16] Capital Expenditures and Liquidity - Capital spending fell to $8 million in Q4, with final capital costs for the Florence project at $275 million, about 3% over budget [18] - The company ended the year with CAD 188 million in cash and a total liquidity of approximately CAD 340 million [20] Project Pipeline - The Yellowhead project is now primarily in the permitting phase, with active engagement with regulators and local communities [21] - Discussions with potential joint venture partners for the New Prosperity project are anticipated to advance over the next year or two [21]

Erie Indemnity Reports Full Year and Fourth Quarter 2025 Results [Accessibility Statement] Skip NavigationNet Income per Diluted Share was $1.21 for the Quarter and $10.69 for the YearERIE, Pa., Feb. 23, 2026 /PRNewswire/ -- Erie Indemnity Company (NASDAQ: ERIE) today announced financial results for the full year and quarter ending December 31, 2025. Net income was $559.3 million, or $10.69 per diluted share, in 2025, compared to $600.3 million, or $11.48 per diluted share, in 2024. Net income was $63.4 mil ...

Financial Data and Key Metrics Changes - B2Gold achieved record revenue of $3 billion for the year 2025, with Q4 revenues recorded at $1.05 billion [2][4] - GAAP earnings were reported at $0.13 per share, with adjusted earnings at $0.11 per share, impacted by the timing of shipments at Fekola [4] - Operating cash flows for 2025 totaled $896 million, including $286 million in Q4, highlighting strong cash generation potential [5] - Cash and cash equivalents stood at $380 million at the end of 2025, with a drawn amount of $150 million on the revolver [5] Business Line Data and Key Metrics Changes - The company produced approximately 980,000 ounces of gold in 2025, near the midpoint of guidance, with expectations for 2026 production between 820,000 and 970,000 ounces [9][10] - Fekola produced over 20,000 ounces from underground operations in 2025, with expectations for consistent production throughout 2026 [2][11] - Masbate operations achieved a record for the second consecutive year, maintaining a world-class safety track record [13] - Otjikoto had strong production in 2025 but is expected to see lower production in 2026 due to the transition to underground mining [15] Market Data and Key Metrics Changes - The company is positioned to take advantage of a strong gold price environment, with growth capital spending at Goose now complete [3] - Fekola Regional is expected to contribute between 60,000 and 80,000 ounces in 2026, with production ramping up in the second half of the year [11] Company Strategy and Development Direction - B2Gold is focused on extending mine lives and returning capital to shareholders, with share repurchases initiated under the NCIB [6] - The company announced an approved construction decision on the Antelope underground deposit, which could increase Otjikoto gold production into the 2030s [3] - The company is studying improvements to the crushing circuit at Goose to increase capacity and operational efficiency [12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in receiving the Fekola Regional exploitation permit in Q1 2026, citing ongoing dialogue with the government [20] - The company anticipates strong cash flow years ahead, with expectations of significant shareholder value addition [6][7] - Management noted that all operations have performed above expectations so far in 2026, despite some operational challenges [10] Other Important Information - The company repurchased 2 million shares for about $10 million in 2025 and an additional 5 million shares for approximately $24 million post-year-end [6] - Initial modifications to improve the crushing circuit at Goose are scheduled for implementation in the second half of 2026 [12] Q&A Session Summary Question: Update on Fekola Regional permit status - Management expressed confidence in receiving the permit soon, citing endorsements from key government officials and ongoing dialogue [19][20] Question: Details on the permanent crusher solution at Goose - The study by FLSmidth has been completed and is under review, with final answers expected by April [21] Question: Clarification on throughput and production capacity - Management explained that while the system can run at 4,000 tons per day, maintaining that level consistently is challenging due to design factors [26][27] Question: Production expectations for Otjikoto and Antelope - Management confirmed that 2027 and 2028 will be build-up years, with production ramping up in 2029 [29] Question: AISC guidance at Goose - Management indicated that AISC is expected to step down significantly once the new crushing circuit is operational [39]

B2Gold (NYSEAM:BTG) Q4 2025 Earnings call February 19, 2026 11:00 AM ET Speaker5Thank you for standing by. This is the conference operator. Welcome to B2Gold Corporation's fourth quarter and 2025 year-end financial results conference call. As a reminder, all participants are in listen-only mode, and the conference is being recorded. After the presentation, there will be an opportunity for analysts to ask questions. To join the question queue, you may press Star, then one on your telephone keypad. You will h ...

Core Viewpoint - CenterPoint Energy, Inc. reported a net income of $264 million for Q4 2025, reflecting a growth in earnings per diluted share compared to the previous year [1] Financial Performance - The company achieved a GAAP earnings per diluted share of $0.40 in Q4 2025, up from $0.38 in Q4 2024 [1] - Non-GAAP earnings per diluted share for Q4 2025 were reported at $0.45, an increase from $0.40 in the same period of 2024 [1] Drivers of Performance - The strong results in the fourth quarter were primarily attributed to growth and regulatory recovery [1]